Using induced pluripotent stem cells as a platform for ALS Dr. Nicholas John Maragakis, M.D

MDA Funding of Research and Care to Unlock the Cure for ALS Continues - Nicholas MaragakisПодробнее

Keynote Presentation at 2022 Les Turner Symposium on ALSПодробнее

HEALEY ALS Platform Trial Weekly Q&A Webinar: March 16, 2023 | Massachusetts General HospitalПодробнее

Induced Pluripotent Stem Cells (iPSC) Part 2: Research and TherapyПодробнее

Using Stem Cells to Model and Treat ALS by Dr. Clive SvendsenПодробнее

Human Induced Pluripotent Stem Cells Reprogrammed From Adult Fibroblasts l Protocol PreviewПодробнее

Nicolas Maragakis, MD discusses ALS research and Stem CellsПодробнее

Dr Nicholas Maragakis on ALS Stem Cell ResearchПодробнее

The Expanding Landscape of Therapeutic Targets in ALS Clinical TrialsПодробнее

Corneal Epithelial Stem Cells Derived from Pluripotent Stem Cells | Protocol PreviewПодробнее

Dr. Jeff Rothstein MD PhD of Johns Hopkins re Personalized Medicine in ALSПодробнее

Update: Clinical Trials Using Stem Cells for Treatment of ALS at Mayo ClinicПодробнее

Stanford Course - Stem Cell TherapeuticsПодробнее

Induced Pluripotent Stem Cells (iPSC) Part 4: Continued ResearchПодробнее

Modeling ALS using stem cells | Sarah LépineПодробнее

Induced Pluripotent Stem Cells // Engineering Explainers #2Подробнее

What are induced pluripotent stem cells? - Dr Andrew Laslett explainsПодробнее

Mesenchymal Stem CellTherapies for ALS from Dr Nathan StaffПодробнее